These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19632574)

  • 1. High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII.
    Bruckner BA; DiBardino DJ; Ning Q; Adeboygeun A; Mahmoud K; Valdes J; Eze J; Allison PM; Cooley DA; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2009 Aug; 28(8):785-90. PubMed ID: 19632574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2008 Mar; 39(3):850-6. PubMed ID: 18239180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.
    Gandhi MJ; Pierce RA; Zhang L; Moon MR; Despotis GJ; Moazami N
    J Cardiothorac Surg; 2007 Jul; 2():32. PubMed ID: 17617902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding.
    Bucklin MH; Acquisto NM; Nelson C
    Thromb Res; 2014 May; 133(5):768-71. PubMed ID: 24636870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic events.
    Brophy GM; Candeloro CL; Robles JR; Brophy DF
    Ann Pharmacother; 2013 Apr; 47(4):447-54. PubMed ID: 23535812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
    Raivio P; Suojaranta-Ylinen R; Kuitunen AH
    Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
    O'Connell KA; Wood JJ; Wise RP; Lozier JN; Braun MM
    JAMA; 2006 Jan; 295(3):293-8. PubMed ID: 16418464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.
    Tarzia V; Buratto E; Bortolussi G; Paolini C; Bejko J; Bottio T; Gerosa G
    Artif Organs; 2015 Mar; 39(3):248-53. PubMed ID: 25065398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven
    Marsh K; Green D; Raco V; Papadopoulos J; Ahuja T
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720924255. PubMed ID: 32449469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Recombinant Factor VII as Rescue for Severe Perioperative Bleeding in HeartMate II Recipients.
    Karimi A; Daigle SS; Smith WB; Janelle GM; Klodell CT
    J Card Surg; 2015 Jun; 30(6):500-5. PubMed ID: 25939953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of recombinant activated factor VII in randomized clinical trials.
    Levi M; Levy JH; Andersen HF; Truloff D
    N Engl J Med; 2010 Nov; 363(19):1791-800. PubMed ID: 21047223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric off-label use of recombinant factor VIIa.
    Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
    Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.